Stay updated on PCSK9 Inhibitors in HoFH Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.

Latest updates to the PCSK9 Inhibitors in HoFH Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check32 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check47 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check61 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check69 days agoChange DetectedThe website has updated the intervention details to include a verified status by Shenzhen People's Hospital and has upgraded to revision v2.14.0, while the previous type of intervention has been removed in revision v2.13.3.SummaryDifference3%
- Check97 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to PCSK9 Inhibitors in HoFH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.